Advertisement

Osteoporosis International

, Volume 29, Issue 2, pp 421–431 | Cite as

Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study

  • M. Osima
  • T. T. Borgen
  • M. Lukic
  • G. Grimnes
  • R. M. Joakimsen
  • E. F. Eriksen
  • Å. Bjørnerem
Original Article

Abstract

Summary

Serum parathyroid hormone (PTH) was associated with increased bone turnover markers and cortical porosity of the inner transitional zone at the proximal femur. These results suggest that PTH through increased intracortical bone turnover leads to trabecularisation of inner cortical bone in postmenopausal women.

Introduction

Vitamin D deficiency leads to secondary hyperparathyroidism and increased risk for fractures, whereas its association with cortical porosity is less clear. We tested (i) whether serum 25-hydroxyvitamin D (25(OH)D) and PTH were associated with cortical porosity and (ii) whether the associations of 25(OH)D) and PTH with fracture risk are dependent on cortical porosity.

Methods

This case-control study included 211 postmenopausal women, 54–94 years old, with prevalent fractures and 232 controls from the Tromsø Study. Serum 25(OH)D, PTH, and bone turnover markers (procollagen type I N-terminal propeptide [PINP] and C-terminal cross-linking telopeptide of type I collagen [CTX]) were measured. Femoral subtrochanteric cortical and trabecular parameters were quantified using computed tomography, and femoral neck areal bone mineral density (FN aBMD) was quantified using dual-energy X-ray absorptiometry.

Results

Compared with controls, fracture cases exhibited reduced serum 25(OH)D and increased PTH, PINP, and CTX, increased femoral subtrochanteric cortical porosity, and reduced cortical thickness and FN aBMD (all, p < 0.05). Serum 25(OH)D was not associated with cortical parameters (all, p > 0.10). PTH was associated with increased PINP, CTX, and cortical porosity of the inner transitional zone and reduced trabecular bone volume/tissue volume and FN aBMD (p ranging from 0.003 to 0.054). Decreasing 25(OH)D and increasing PTH were associated with increased odds for fractures, independent of age, height, weight, calcium supplementation, serum calcium, cortical porosity, and thickness.

Conclusions

These data suggest that serum PTH, not 25(OH)D, is associated with increased intracortical bone turnover resulting in trabecularisation of the inner cortical bone; nevertheless, decreasing 25(OH)D) and increasing PTH are associated with fracture risk, independent of cortical porosity and thickness.

Keywords

25-Hydroxyvitamin D Bone turnover markers Cortical porosity Non-vertebral fracture Parathyroid hormone 

Notes

Acknowledgements

The authors would like to acknowledge the Tromsø Study which provided access to data, staff at the Department of Research at the University Hospital of North Norway (UNN) who recruited women, staff at the Department of Radiology and Department of Radiation, UNN, who scanned the patients and organised the radiation procedures and the CT images, and Strax Corp., Melbourne, which analysed the CT images.

Funding

The North Norwegian Health Authorities funded the study (ID 5645/SFP1002-11, ID 9167/SFP1090-13, ID 9168/SFP1135-13, ID 10295/SFP1206-14, ID 12156/HNF1386-17), but had no role in the design and conduct of the study; in the collection, analyses, and interpretation of the data; or in the preparation, review, or approval of the manuscript.

Compliance with ethical standards

All participants provided written informed consent; the study was approved by the Regional Committee of Research Ethics and was conducted in accordance with the World Medical Association Declaration of Helsinki.

Conflicts of interest

None.

References

  1. 1.
    Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D et al (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212–1221CrossRefPubMedGoogle Scholar
  2. 2.
    Parfitt AM, Gallagher J, Heaney RP, Johnston C, Neer R, Whedon GD (1982) Vitamin D and bone health in the elderly. Am J Clin Nutr 36(5 Suppl):1014–1031CrossRefPubMedGoogle Scholar
  3. 3.
    Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92:4–8CrossRefPubMedGoogle Scholar
  4. 4.
    Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501CrossRefPubMedGoogle Scholar
  5. 5.
    Pasco JA, Henry MJ, Kotowicz MA, Sanders KM, Seeman E, Pasco JR et al (2004) Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19:752–758CrossRefPubMedGoogle Scholar
  6. 6.
    Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD et al (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177–1184CrossRefPubMedGoogle Scholar
  7. 7.
    Holvik K, Ahmed LA, Forsmo S, Gjesdal CG, Grimnes G, Samuelsen SO et al (2013) Low serum levels of 25-hydroxyvitamin D predict hip fracture in the elderly: a NOREPOS study. J Clin Endocrinol Metab 98:3341–3350CrossRefPubMedGoogle Scholar
  8. 8.
    Cauley JA, LaCroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC et al (2008) Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 149:242–250CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40–49CrossRefPubMedGoogle Scholar
  10. 10.
    Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642CrossRefPubMedGoogle Scholar
  11. 11.
    Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716CrossRefPubMedGoogle Scholar
  12. 12.
    Ebeling PR (2014) Vitamin D and bone health: epidemiologic studies. Bonekey Rep 3:511CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244CrossRefPubMedGoogle Scholar
  14. 14.
    Cauley JA, Chalhoub D, Kassem AM, Fuleihan GE-H (2014) Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol 10:338–351CrossRefPubMedGoogle Scholar
  15. 15.
    Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E (2004) Vitamin D status of middle-aged women at 65–71 N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 7:327–335PubMedGoogle Scholar
  16. 16.
    Engelsen O, Brustad M, Aksnes L, Lund E (2005) Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81:1287–1290CrossRefPubMedGoogle Scholar
  17. 17.
    Melhus HK, Snellman G, Gedeborg R, Byberg L, Berglund L, Mallmin H et al (2010) Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab 95:2637–2645CrossRefPubMedGoogle Scholar
  18. 18.
    Halfon M, Phan O, Teta D (2015) Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty. Biomed Res Int 2015:953241CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Bala Y, Zebaze R, Ghasem-Zadeh A, Atkinson EJ, Iuliano S, Peterson JM et al (2014) Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res 29:1356–1362CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ahmed L, Shigdel R, Joakimsen R, Eldevik O, Eriksen E, Ghasem-Zadeh A et al (2015) Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporos Int 26:2137–2146CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bjørnerem Å (2016) The clinical contribution of cortical porosity to fragility fractures. Bonekey Rep 5:846CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sundh D, Mellström D, Nilsson M, Karlsson M, Ohlsson C, Lorentzon M (2015) Increased cortical porosity in older men with fracture. J Bone Miner Res 30:1692–1700CrossRefPubMedGoogle Scholar
  23. 23.
    Shigdel R, Osima M, Ahmed LA, Joakimsen RM, Eriksen EF, Zebaze R et al (2015) Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures. Bone 81:1–6CrossRefPubMedGoogle Scholar
  24. 24.
    Shigdel R, Osima M, Lukic M, Ahmed LA, Joakimsen RM, Eriksen EF et al (2016) Determinants of transitional zone area and porosity of the proximal femur quantified in vivo in postmenopausal women. J Bone Miner Res 31:758–766CrossRefPubMedGoogle Scholar
  25. 25.
    Sundh D, Mellström D, Ljunggren Ö, Karlsson M, Ohlsson C, Nilsson M et al (2016) Low serum vitamin D is associated with higher cortical porosity in elderly men. J Intern Med 280:496–508CrossRefPubMedGoogle Scholar
  26. 26.
    Boyd S, Burt L, Sevick L, Hanley D (2015) The relationship between serum 25 (OH) D and bone density and microarchitecture as measured by HR-pQCT. Osteoporos Int 26:2375–2380CrossRefPubMedGoogle Scholar
  27. 27.
    Chaitou A, Boutroy S, Vilayphiou N, Varennes A, Richard M, Blaizot S et al (2011) Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. Eur J Endocrinol 165:151–159CrossRefPubMedGoogle Scholar
  28. 28.
    Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I (2012) Cohort profile: the Tromsø study. Int J Epidemiol 41:961–967CrossRefPubMedGoogle Scholar
  29. 29.
    Bjørnerem Å, Ahmed LA, Jørgensen L, Størmer J, Joakimsen RM (2011) Breastfeeding protects against hip fracture in postmenopausal women: the Tromsø study. J Bone Miner Res 26:2843–2850CrossRefPubMedGoogle Scholar
  30. 30.
    Shigdel R (2016) Cortical porosity as a target for fracture prevention: the Tromsø study. Thesis/Dissertation ISBN 978 82 7589 496 8Google Scholar
  31. 31.
    Osima M, Kral R, Borgen TT, Høgestøl IK, Joakimsen RM, Eriksen EF et al (2017) Women with type 2 diabetes mellitus have lower cortical porosity of the proximal femoral shaft using low-resolution CT than nondiabetic women, and increasing glucose is associated with reduced cortical porosity. Bone 97:252–260CrossRefPubMedGoogle Scholar
  32. 32.
    Zebaze R, Ghasem-Zadeh A, Mbala A, Seeman E (2013) A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images. Bone 54:8–20CrossRefPubMedGoogle Scholar
  33. 33.
    Zebaze R, Libanati C, McClung MR, Zanchetta JR, Kendler DL, Høiseth A et al (2016) Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis. J Bone Miner Res 31:1827–1834CrossRefPubMedGoogle Scholar
  34. 34.
    Bjørnerem Å, Ghasem-Zadeh A, Bui M, Wang X, Rantzau C, Nguyen TV et al (2011) Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: a twin study. Bone 49:1125–1130CrossRefPubMedGoogle Scholar
  35. 35.
    Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300Google Scholar
  36. 36.
    Zebaze R, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI et al (2010) Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375:1729–1736CrossRefPubMedGoogle Scholar
  37. 37.
    Bala Y, Zebaze R, Seeman E (2015) Role of cortical bone in bone fragility. Curr Opin Rheumatol 27:406–413CrossRefPubMedGoogle Scholar
  38. 38.
    Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 115:505–512CrossRefPubMedGoogle Scholar
  39. 39.
    Shah S, Chiang C, Sikaris K, Lu Z, Bui M, Zebaze R et al (2017) Serum 25-hydroxyvitamin D insufficiency in search of a bone disease. J Clin Endocrinol Metab 102:2321–2328CrossRefPubMedGoogle Scholar
  40. 40.
    Mezquita-Raya P, Muñoz-Torres M, De Dios Luna J, Luna V, Lopez-Rodriguez F, Torres-Vela E et al (2001) Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res 16:1408–1415CrossRefPubMedGoogle Scholar
  41. 41.
    Bischoff-Ferrari HA, Dawson-Hughes B (2016) Vitamin D and fall prevention: an update. In: Weaver CM (ed) Nutritional influences on bone health, 9th edn. Springer, Switzerland, pp 197–205CrossRefGoogle Scholar
  42. 42.
    TD V, Wang XF, Wang Q, Cusano NE, Irani D, Silva BC et al (2013) New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone 55:57–63CrossRefGoogle Scholar
  43. 43.
    Barbour KE, Houston DK, Cummings SR, Boudreau R, Prasad T, Sheu Y et al (2012) Calciotropic hormones and the risk of hip and nonspine fractures in older adults: the Health ABC Study. J Bone Miner Res 27:1177–1185CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Zebaze R, Seeman E (2015) Cortical bone: a challenging geography. J Bone Miner Res 30:24–29CrossRefPubMedGoogle Scholar
  45. 45.
    Hewitt S, Søvik TT, Aasheim ET, Kristinsson J, Jahnsen J, Birketvedt GS et al (2013) Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg 23:384–390CrossRefPubMedGoogle Scholar
  46. 46.
    Devold HM, Sogaard AJ, Tverdal A, Falch JA, Furu K, Meyer HE (2013) Hip fracture and other predictors of anti-osteoporosis drug use in Norway. Osteoporos Int 24:1225–1233CrossRefPubMedGoogle Scholar
  47. 47.
    Hoff M, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U et al (2015) Use of anti-osteoporotic drugs in central Norway after a forearm fracture. Arch Osteoporos 10:235CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2017

Authors and Affiliations

  • M. Osima
    • 1
    • 2
  • T. T. Borgen
    • 3
  • M. Lukic
    • 1
  • G. Grimnes
    • 4
    • 5
  • R. M. Joakimsen
    • 4
    • 5
  • E. F. Eriksen
    • 6
    • 7
  • Å. Bjørnerem
    • 5
    • 8
  1. 1.Department of Community Medicine, Faculty of Health SciencesUiT, The Arctic University of NorwayTromsøNorway
  2. 2.Department of Orthopaedic SurgeryUniversity Hospital of North NorwayTromsøNorway
  3. 3.Department of RheumatologyVestre Viken Hospital Trust, Hospital of DrammenDrammenNorway
  4. 4.Department of MedicineUniversity Hospital of North NorwayTromsøNorway
  5. 5.Department of Clinical MedicineUiT The Arctic University of NorwayTromsøNorway
  6. 6.Department of Endocrinology, Morbid Obesity and Preventive MedicineOslo University HospitalOsloNorway
  7. 7.Institute of Clinical MedicineUniversity of OsloOsloNorway
  8. 8.Department of Obstetrics and GynaecologyUniversity Hospital of North NorwayTromsøNorway

Personalised recommendations